Partnership Opportunities

The Adenosine-Pathway Targeted Cancer Immunotherapy Summit unites a highly focused community of experts working to support the collective mission of supercharging adenosine-pathway therapies to patients in need.

Showcase how your company enables drug developers to overcome the barriers to developing truly curative Adenosine Targeted Immunotherapies, such as tumor models, immunoassays, diagnostics and biomarkers, and CRO. Whether this is through speaking on the agenda, hosting networking sessions or exhibiting, we’ll work with you to build a bespoke partnership to ensure that you meet your 2022 business objectives.

Benefit from
Market
Intelligence

Address the field’s current unmet needs an hear how and where pharmaceutical giants are looking for services and solutions to facilitate their R&D platforms

Meet & Network with Industry Pioneers

Meet prospective clients during structured networking breaks, bespoke 1-2-1 meetings and more informal networking receptions

Position Yourself as an Industry Expert

Showcase your independent expertise in front of the key decision-makers in the field including biotech companies focused on developing adenosine inhibitors, large pharma and investors

Raise your Brand Awareness

Benefit from post-conference exposure to our KOL community and increase market share through unique branding formats

Generate Commercial Collaborations

Ensure your hottest prospects are in the room and part of the discussion by having a wish-list of your choice contacted in advance of the event

Get in touch today to learn more about how we can help you make the right connections within the adenosine-pathway targeted cancer immunotherapy field